Search - tctmd.com

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Side Branch Dilatation Helpful Before T-Stenting of Bifurcation Lesions

Caitlin E. Cox

May 24, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

News Conference News EuroPCR 2013

RIPCORD Study: FFR Results Change Path of Patient Management

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

Jason Kahn

May 18, 2012

News Conference News EuroPCR 2012

OCT-Guided PCI Improves 1-Year Outcomes vs. Angiography Alone

Jason Kahn

May 18, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

Advertisement

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Side Branch Dilatation Helpful Before T-Stenting of Bifurcation Lesions

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

RIPCORD Study: FFR Results Change Path of Patient Management

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

OCT-Guided PCI Improves 1-Year Outcomes vs. Angiography Alone

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content